Contribute Try STAT+ Today

In a cautiously worded essay, the Food and Drug Administration commissioner and more than a dozen other agency officials are trying to temper enthusiasm for a controversial provision in the 21st Century Cures Act, which was signed into law on Tuesday by President Obama.

The subject of their treatise is real-world evidence, a euphemism for various sorts of data that the law would allow the agency to use for approving additional uses of medicines, as well as for any follow-up studies that may be required. Such evidence could include electronic health records, observational studies, ongoing safety monitoring, claims data, and patient registries, among other things.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Skip this whole “efficacy” nonsense for drug approval, “safety” (doesn’t kill you within, let’s say, 3 weeks) is good enough! GREAT! again…

Comments are closed.